Related Experiment Video
Updated: Mar 24, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Use of forms for follow-up of diabetes in general practice
Lillebeth Larun1, Trine Bjørner2, Atle Fretheim3
1Kunnskapssenteret i Folkehelseinstituttet og Senter for kunnskapsbasert praksis Høgskolen i Bergen.
Background:
The majority of patients with type 2 diabetes are followed up in general practice. We have investigated whether the use of forms by GPs for recording clinical data contributes to lower mortality and morbidity for this patient group.
Material And Method:
This systematic review is based on literature searches in MEDLINE, EMBASE, ISI Web of Science, Cochrane CENTRAL and PubMed. We included studies that 1) dealt with adults over 18 years of age with diabetes who were followed up in the primary health service and 2) compared mortality and morbidity with and without the use of forms. We summarised the results qualitatively and using meta-analyses.
Results:
Seven studies were included. One study (1262 participants) investigated the effect of the form on hard endpoints, without finding clear effects on mortality (HR 0.91; 95% CI 0.72-1.14), retinopathy (OR 0.90; 95% CI 0.53-1.52), peripheral nerve injury (OR 0.86; 95% CI 0.57-1.29), myocardial infarction (OR 0.65; 95% CI 0.31-1.35) or stroke (OR 0.89; 95% CI 0.39-2.01). Use of forms appears to have little or no effect on body weight (3 studies), and a small, positive effect on blood pressure (5 studies) and total cholesterol (2 studies).
Interpretation:
Published data at present provide no clear answers, but shows that use of forms in the follow-up of patients with diabetes in general practice may tend to contribute to lower mortality and morbidity.
More Related Videos
07:51Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into...